01235 838 500

BOOK A TOUR
Back To News More

MitoRx Publishes Study on AP39’s Effectiveness in Reducing Obesity

October 17th 2024

MitoRx Therapeutics has published a study in Pharmacological Research demonstrating that its mitochondrial-targeted sulfide-donor compound, AP39, significantly reduces weight gain and fatty liver. This study is the first to explore the potential of mitochondrial sulfide donors in addressing obesity-related disorders.

AP39 was found to reduce weight gain by 32%, lower triglycerides, and decrease inflammatory markers, suggesting it affects lipid metabolism through the mTOR/SREBP-1/SCD1 pathway. MitoRx is developing next-generation compounds that not only combat obesity but also protect muscle, potentially addressing muscle loss associated with existing obesity treatments like GLP-1 receptor agonists.

Dr Jon Rees, CEO of MitoRx, emphasised the importance of this research in providing a new therapeutic avenue for metabolic diseases while mitigating side effects associated with current treatments. The lead author, Dr Aneta Stachowicz, highlighted the significance of this work in advancing innovative treatments for metabolic disorders through the modulation of mitochondrial signalling.

 

To read the full article or to stay up to date with further developments please follow the link – MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity

More

February 19th 2026

Harwell Campus launches public consultation to shape its vision as it looks to its centenary

Harwell Science and Innovation Campus has launched a public consultation inviting local communities, businesses and stakeholders to help shape the next chapter of its long-term plans, as the campus looks ahead to its 100th anniversary. Building on more than 80 years at the forefront of UK scientific discovery, Harwell is […]

Read
January 6th 2026

Supporting Astroscale UK’s mission to clean up space

At Harwell Innovation Centre, we are proud to have supported Astroscale UK during the early stages of its journey to tackle the growing challenge of space debris and advance technologies for satellite maintenance and servicing. Astroscale UK, an in-orbit servicing company often described as the “AA of space”, established its […]

Read Case Study
November 14th 2025

New Quantum Cluster aims to create 1,000 high-value jobs and attract £1 billion investment over next decade

The UK’s new Harwell Quantum Cluster officially launched yesterday at the Harwell Science and Innovation Campus, marking a pivotal step in the nation’s ambition to lead the global quantum revolution. The cluster will accelerate quantum innovation, scale emerging technologies, and aim to create over 1,000 high-value jobs and £1 billion […]

Read